Caption Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.1M | Buy |
245,000
+217,001
| +775% | +$13.8M | 0.77% | 232 |
|
|
2025
Q4 | $1.78M | Sell |
27,999
-2,358
| -8% | -$147K | 0.08% | 875 |
|
|
2025
Q3 | $1.67M | Buy |
30,357
+11,357
| +60% | +$468K | 0.1% | 918 |
|
|
2025
Q2 | $628K | Sell |
19,000
-39,739
| -68% | -$1.38M | 0.06% | 1058 |
|
|
2025
Q1 | $2.36M | Buy |
58,739
+3,909
| +7% | +$180K | 0.11% | 634 |
|
|
2024
Q4 | $2.58M | Buy |
54,830
+21,330
| +64% | +$1.11M | 0.11% | 610 |
|
|
2024
Q3 | $1.77M | Sell |
33,500
-33,500
| -50% | -$1.87M | 0.19% | 604 |
|
|
2024
Q2 | $3.63M | Sell |
67,000
-198,554
| -75% | -$12M | 0.38% | 345 |
|
|
2024
Q1 | $18.6M | Sell |
265,554
-154,805
| -37% | -$12M | 2.05% | 77 |
|
|
2023
Q4 | $35.1M | Buy |
420,359
+405,284
| +2,688% | +$14.7M | 3.82% | 35 |
|
|
2023
Q3 | $444K | Buy |
+15,075
| New | +$502K | 0.06% | 959 |
|
|
2023
Q1 | – | Sell |
-100,354
| Closed | -$4.6M | – | 1271 |
|
|
2022
Q4 | $4.6M | Buy |
+100,354
| New | +$4.32M | 0.78% | 321 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1637 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1585 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1628 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1725 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1645 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1445 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1196 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1084 |
|
|
2020
Q3 | – | Sell |
-61,600
| Closed | -$1.44M | – | 1124 |
|
|
2020
Q2 | $1.45M | Buy |
61,600
+19,864
| +48% | +$372K | 0.3% | 446 |
|
|
2020
Q1 | $492K | Buy |
+41,736
| New | +$532K | 0.16% | 547 |
|
|
2019
Q4 | – | Sell |
-14,400
| Closed | -$164K | – | 905 |
|
|
2019
Q3 | $164K | Sell |
14,400
-15,600
| -52% | -$196K | 0.05% | 604 |
|
|
2019
Q2 | $337K | Buy |
+30,000
| New | +$289K | 0.12% | 521 |
|
Other funds holding CYTK
VPM
VCM
ACA
